Evidence map›Paper›PMID 25114467›Full record

ReviewIndian journal of surgical oncology2014

Chemotherapy and targeted therapy for gall bladder cancer.

Bhawna Sirohi, Ashish Singh, P Jagannath, Shailesh V Shrikhande

Open access · bronzeAbstract readReview
In one paragraph

Review in Indian journal of surgical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cystadenocarcinoma of the gallbladder: A case report.Annals of medicine and surgery (2012) · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Indian Council of Medical Research consensus document for the management of gall bladder cancer.Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bhawna SirohiDepartment of Medical Oncology, TMC Tata Memorial Centre, Parel Mumbai, 400012 India.
Ashish SinghDepartment of Medical Oncology, TMC Tata Memorial Centre, Parel Mumbai, 400012 India.
P JagannathDepartment of Surgical Oncology, Lilavati Hospital and Research centre, Tata Memorial Centre (TMC), Mumbai, India.
Shailesh V ShrikhandeDepartment of GI & HPB Surgery, TMC, Tata Memorial Centre (TMC), Mumbai, India.
Tata Memorial Hospital · INLilavati Hospital & Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gall bladder cancer is a common cancer in the Ganges belt of North-eastern India. In view of incidental diagnosis of gall bladder cancer by physicians and surgeons, the treatment is not optimised. Most patients present in advanced stages and surgery remains the only option to cure. This review highlights the current evidence in advances in systemic therapy of gall bladder cancer.

Indexed as

ChemotherapyGall bladder cancerTargeted therapy

Identifiers

PMID25114467
PMCPMC4116538
OpenAlexW2119370688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.